BANCAP Drug Patent Profile
When do Bancap patents expire, and when can generic versions of Bancap launch?
Bancap is a drug marketed by Forest Pharms and is included in two NDAs.
The generic ingredient in BANCAP is acetaminophen; hydrocodone bitartrate. There are two drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BANCAP?
- What are the global sales for BANCAP?
- What is Average Wholesale Price for BANCAP?
Summary for BANCAP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 7 |
| DailyMed Link: | BANCAP at DailyMed |
US Patents and Regulatory Information for BANCAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Pharms | BANCAP | acetaminophen; butalbital | CAPSULE;ORAL | 088889-001 | Jan 16, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Forest Pharms | BANCAP HC | acetaminophen; hydrocodone bitartrate | CAPSULE;ORAL | 087961-001 | Mar 17, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
